Drugs / Autologous Cytokine Rich Serum
Autologous Cytokine Rich Serum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04194710 Comparator | Dec 2020 → Jul 2023 | epicondylitis | Corporacion Parc Tauli | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Cytokine Rich Serum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04194710 ↗ |
| Modality | Protein / enzyme biologic | “proteins derived from the patient's own blood” NCT04194710 ↗ |
| Route | Other | “This Cytokine Rich Serum is then injected to the epicondyle.” NCT04194710 ↗ |